Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS HB 04 B-BOOST intensified versus standard hepatitis B revaccination in HIV-infected non-responders
2007-005023-15Phase 3Active
- Sponsor
- ANRS
- Start
- Jan 2008
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by ANRS. Primary endpoint: Seroconversion rate at week 28. Started Jan 2008; status: active.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2007-005023-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005023-15.